the Scientific Revolution

 The current inflection point in medical history means access to new treatments makes all the difference, and we need to bring advances safely and economically to as many people as possible. 

Many of these advances provide hope for a cure for metastatic breast cancer (MBC). Despite decades of research, the survival rate of stage 4 at 5 years is 32%.¹ But across the world, researchers, institutions, and organizations are pursuing pathbreaking research to find curative therapies that MBC patients need.

To Michele, this is a personal mission. She is right now on targeted chemotherapy and cannot wait for the discoveries that are ten or fifteen years away. It will decide whether she can walk her children down the wedding aisle. The science is there. It needs to be harnessed. Without it, research sits on the shelves. Michele is inspired by the success of other non-profits bringing life-saving treatments to patients, including the work of Kathy Giusti, Michael Fox, and  David Feigenbaum. They found a way to save their lives and all others. It cannot be done without tremendous support, but if possible, not one life would be saved, but millions for years to come. Michele wants her vision to be a legacy of hope for women facing breast cancer.